AstraZeneca Korea Appoints Jaeyoon Lim as New Country Medical Director

Lim Jaeyoon, New Head of Medical Affairs at AstraZeneca Korea
[Photo by AstraZeneca Korea]

AstraZeneca Korea announced on May 4 that Jaeyoon Lim, Executive Director of Medical Affairs, has been appointed as the new Head of Medical Affairs (Country Medical Director).

Lim, the newly appointed Head, is a board-certified medical oncologist who graduated from Yonsei University College of Medicine. He accumulated approximately eight years of clinical experience, serving as a postdoctoral researcher at the MD Anderson Cancer Center at the University of Texas in the United States, as well as a professor at Yonsei University College of Medicine. He has been actively involved in academic activities both domestically and internationally as a full member of the Korean Cancer Association, the American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO). After leading clinical development of anticancer drugs at Samsung Bioepis, he joined AstraZeneca Korea in 2019 as the Oncology Therapeutic Area Lead within the Medical Affairs division.

Since joining AstraZeneca Korea, Lim has been recognized for delivering the medical value of oncology products and strengthening AstraZeneca's scientific leadership throughout the processes of clinical trials, product launches, reimbursement, and partnerships. In particular, as the oncology portfolio rapidly expanded, he played a key role in communicating the medical value and driving the performance of the Medical Affairs division with the launch, label expansion, and reimbursement of major oncology products such as Tagrisso, Imfinzi, Enhertu, Lynparza, and Koselugo.

Meanwhile, AstraZeneca Korea also announced that Yuseon Nam, Executive Director of Medical Affairs, will be promoted to the global Medical Lead for the Cardiovascular, Renal, and Metabolism (CVRM) business unit starting June 1. Including Nam, a total of eight AstraZeneca Korea employees have successfully advanced to global roles based on their achievements in Korea since 2020, positioning AstraZeneca Korea as a key hub for global talent development. The list includes: Woo Jeongja, Chief Financial Officer (CFO) for AstraZeneca Asia; Jun Sehwan, Country President of AstraZeneca Indonesia; Kim Suyeon, Country President of AstraZeneca Singapore; Kim Sohyun, Head of Oncology Clinical Team for Asia, Middle East, and Africa at AstraZeneca; Do Hyunwoong, Global Marketing Lead for Vaccines and Immunology in the International Region at AstraZeneca; Kim Yunkyung, Head of Business Development for AstraZeneca Asia; and Lee Juyeon, Women’s Cancer Diagnostics Lead for the Oncology Business Unit in the International Region at AstraZeneca-all of whom are former employees of AstraZeneca Korea now active in global roles.

Sangpyo Kim, Country President of AstraZeneca Korea, stated, "AstraZeneca Korea has always prioritized talent development and has continuously made efforts and investments in collaboration with headquarters to foster talent. We are delighted that with Lim's promotion, several employees are expanding their roles to global regions." He added, "We believe there will be even more opportunities in the future, and we plan to actively support Korean employees so they can continue to grow within the company."

This content was produced with the assistance of AI translation services.